Marlou M. A. Raets
Research Subjects
Marlou M. A. Raets has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Aranka J. van Wesemael
Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, Amsterdam, The Netherlands
2 shared publications - Chris H. P. van Den Akker
Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, Amsterdam, Netherlands
2 shared publications - Christian Victor Hulzebos
Department of Neonatology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications - Hendrik J. Niemarkt
Department of Neonatology, Máxima Medical Centre, Veldhoven, Netherlands
2 shared publications - Koen Felix Maria Joosten
Department of Neonatal and Paediatric Intensive Care, Erasmus MC - Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, Netherlands
2 shared publications - Marijn Jorien Vermeulen
Department of Neonatal and Pediatric Intensive Care, Division of Neonatology, Sophia Children’s Hospital, Erasmus MC, Rotterdam, Netherlands
2 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (11) , 913
Clinical effects of multi-strain probiotics in extremely preterm infants: a multicenter pre-post implementation study in the Netherlands
Probiotics may reduce the risk of necrotizing enterocolitis (NEC), late-onset sepsis (LOS), and mortality in preterm infants. However, their efficacy in extremely preterm infants (gestational age < 28 weeks) is still regularly questioned due to limited data and safety concerns. In Dutch Neonatal Intensive Care Units (NICUs), a three-strain probiotic product (ProPrems®; Bifidobacterium infantis Bb-02, Bifidobacterium lactis BB-12, and S treptococcus thermophilus TH-4) was implemented as standard of care from 2021 onwards. This study evaluates the clinical effects of these probiotics in extremely preterm infants. Pre- and postimplementation cohorts of extremely preterm infants from 6 Dutch NICUs (2018–2023) were compared. Clinical data from the first 29 days of life were collected. Incidence of NEC (modified Bell’s stage ≥ IIA), LOS, and mortality were compared with logistic regression; growth velocity with linear regression; and time to full enteral feeds (tFEF) with survival analyses. In total, 481 extremely preterm infants (212 pre-, 269 post-implementation) were included. After implementation, the adjusted odds ratio was 0.49 (0.25–0.99; p = 0.049) for NEC; 0.87 (0.59–1.28; p = 0.49) for LOS; and 0.67 (0.35–1.27; p = 0.22) for all-cause mortality. Furthermore, tFEF decreased by 2 days ( p < 0.001) and probiotic use was associated with an increase in growth velocity of 1.8 g/kg/day ( p < 0.001). One infant (0.4%) developed probiotic-associated sepsis. Conclusion : This multicenter pre-postimplementation study showed that multi-strain probiotic administration was associated with lower NEC incidence, shorter tFEF, and greater growth velocity in extremely preterm infants during the first four weeks of life. Probiotic-associated sepsis was rare. These results support continued use of probiotics in this vulnerable population. What is Known: • Certain probiotic strains effectively reduce incidence of necrotizing enterocolitis (NEC) in preterm infants, but the efficacy and safety for extremely preterm infants (GA < 28 weeks) remain under debate. What is New: • This study shows that a multi-strain probiotic supplement was associated with lower NEC incidence, shorter time to full enteral feeds, and greater early postnatal growth in a Dutch multicenter cohort of extremely preterm infants. • The incidence of probiotic-associated sepsis in extremely preterm infants was very low in our cohort with just 1 case (0.4%), consistent with the rare occurrence reported previously.
- 31 October 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (11) , 913
Open AccessClinical effects of multi-strain probiotics in extremely preterm infants: a multicenter pre-post implementation study in the Netherlands
Probiotics may reduce the risk of necrotizing enterocolitis (NEC), late-onset sepsis (LOS), and mortality in preterm infants. However, their efficacy in extremely preterm infants (gestational age < 28 weeks) is still regularly questioned due to limited data and safety concerns. In Dutch Neonatal Intensive Care Units (NICUs), a three-strain probiotic product (ProPrems®; Bifidobacterium infantis Bb-02, Bifidobacterium lactis BB-12, and S treptococcus thermophilus TH-4) was implemented as standard of care from 2021 onwards. This study evaluates the clinical effects of these probiotics in extremely preterm infants. Pre- and postimplementation cohorts of extremely preterm infants from 6 Dutch NICUs (2018–2023) were compared. Clinical data from the first 29 days of life were collected. Incidence of NEC (modified Bell’s stage ≥ IIA), LOS, and mortality were compared with logistic regression; growth velocity with linear regression; and time to full enteral feeds (tFEF) with survival analyses. In total, 481 extremely preterm infants (212 pre-, 269 post-implementation) were included. After implementation, the adjusted odds ratio was 0.49 (0.25–0.99; p = 0.049) for NEC; 0.87 (0.59–1.28; p = 0.49) for LOS; and 0.67 (0.35–1.27; p = 0.22) for all-cause mortality. Furthermore, tFEF decreased by 2 days ( p < 0.001) and probiotic use was associated with an increase in growth velocity of 1.8 g/kg/day ( p < 0.001). One infant (0.4%) developed probiotic-associated sepsis. Conclusion : This multicenter pre-postimplementation study showed that multi-strain probiotic administration was associated with lower NEC incidence, shorter tFEF, and greater growth velocity in extremely preterm infants during the first four weeks of life. Probiotic-associated sepsis was rare. These results support continued use of probiotics in this vulnerable population. What is Known: • Certain probiotic strains effectively reduce incidence of necrotizing enterocolitis (NEC) in preterm infants, but the efficacy and safety for extremely preterm infants (GA < 28 weeks) remain under debate. What is New: • This study shows that a multi-strain probiotic supplement was associated with lower NEC incidence, shorter time to full enteral feeds, and greater early postnatal growth in a Dutch multicenter cohort of extremely preterm infants. • The incidence of probiotic-associated sepsis in extremely preterm infants was very low in our cohort with just 1 case (0.4%), consistent with the rare occurrence reported previously.
- Open Access
- 29 April 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (5) , 323
Lifestyle behaviours in children born extremely preterm at 2 years: a comparison to a Dutch reference population
Children born extremely preterm (EP, < 28 weeks gestation) are at increased risk of lifestyle-related morbidities. This study characterized parent-reported lifestyle behaviours in EP-born children at 2 years’ corrected age (CA) and compared them with a Dutch reference population. In a multicentre prospective cohort study, parents completed the FLY-Kids lifestyle screening questionnaire (2 years’ CA), which assessed parental satisfaction and adherence to age-specific recommendations for diet, eating habits, physical activity, screen time and sleep. Outcomes were compared with a Dutch reference sample of 2-year-olds, and associations were examined using linear regression. Of 269 eligible children, 239 parents responded. After exclusions ( n = 63), 176 children (74%) were enrolled, of whom 115 (65%) completed the questionnaire (14 twin-pairs). Compared with the Dutch reference population ( n = 73), lifestyle recommendations were more often unmet in EP children (mean = 3.92 vs. 3.29 items, p = 0.01). Interestingly, a larger proportion of EP children exceeded the recommended sleep duration (≥ 14 h) ( p < 0.001), while other lifestyle items were similar. In both populations, > 30% of children failed to meet the recommendations for seven out of nine items. Higher socioeconomic status ( p = 0.016) and having at least one foreign-born parent ( p = 0.034) were associated with lower parental satisfaction. Bronchopulmonary dysplasia diagnosis was associated with greater adherence to recommendations ( p < 0.001), while being underweight ( p = 0.029) associated with more unmet recommendations. Conclusion : Despite longer sleep duration, lifestyle behaviours in EP children at 2 years’ CA largely resemble those of the general population. However, poor adherence to lifestyle recommendations highlight the need for targeted interventions to reduce lifestyle-associated morbidities in EP children. What is Known: • Healthy lifestyle behaviours in early childhood are essential for long-term health outcomes. • Extremely preterm (EP)–born children have an elevated risk of lifestyle-related morbidities. However, knowledge on lifestyle behaviours during toddlerhood in this population remains limited. What is New: • Characterization of lifestyle behaviours in this specific group of EP-born children at 2 years’ corrected age offers novel insights. • Except for longer sleep duration, lifestyle behaviours largely resemble the general population. However, over 30% of children in both EP and term populations fail to meet recommendations for 7 of the 9 lifestyle items included in the FLY-Kids tool.
- 29 April 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (5) , 323
Open AccessLifestyle behaviours in children born extremely preterm at 2 years: a comparison to a Dutch reference population
Children born extremely preterm (EP, < 28 weeks gestation) are at increased risk of lifestyle-related morbidities. This study characterized parent-reported lifestyle behaviours in EP-born children at 2 years’ corrected age (CA) and compared them with a Dutch reference population. In a multicentre prospective cohort study, parents completed the FLY-Kids lifestyle screening questionnaire (2 years’ CA), which assessed parental satisfaction and adherence to age-specific recommendations for diet, eating habits, physical activity, screen time and sleep. Outcomes were compared with a Dutch reference sample of 2-year-olds, and associations were examined using linear regression. Of 269 eligible children, 239 parents responded. After exclusions ( n = 63), 176 children (74%) were enrolled, of whom 115 (65%) completed the questionnaire (14 twin-pairs). Compared with the Dutch reference population ( n = 73), lifestyle recommendations were more often unmet in EP children (mean = 3.92 vs. 3.29 items, p = 0.01). Interestingly, a larger proportion of EP children exceeded the recommended sleep duration (≥ 14 h) ( p < 0.001), while other lifestyle items were similar. In both populations, > 30% of children failed to meet the recommendations for seven out of nine items. Higher socioeconomic status ( p = 0.016) and having at least one foreign-born parent ( p = 0.034) were associated with lower parental satisfaction. Bronchopulmonary dysplasia diagnosis was associated with greater adherence to recommendations ( p < 0.001), while being underweight ( p = 0.029) associated with more unmet recommendations. Conclusion : Despite longer sleep duration, lifestyle behaviours in EP children at 2 years’ CA largely resemble those of the general population. However, poor adherence to lifestyle recommendations highlight the need for targeted interventions to reduce lifestyle-associated morbidities in EP children. What is Known: • Healthy lifestyle behaviours in early childhood are essential for long-term health outcomes. • Extremely preterm (EP)–born children have an elevated risk of lifestyle-related morbidities. However, knowledge on lifestyle behaviours during toddlerhood in this population remains limited. What is New: • Characterization of lifestyle behaviours in this specific group of EP-born children at 2 years’ corrected age offers novel insights. • Except for longer sleep duration, lifestyle behaviours largely resemble the general population. However, over 30% of children in both EP and term populations fail to meet recommendations for 7 of the 9 lifestyle items included in the FLY-Kids tool.
- 9 December 2023
- Published by BMJ in BMJ Case Reports
- Vol. 16 (12) , e256014
Cerebral near-infrared spectroscopy for early recognition of impending cardiac tamponade in a preterm neonate
Cardiac tamponade is a rare but life-threatening complication of umbilical venous catheter (UVC) placement in neonates. Mortality rates are high; therefore, early diagnosis is important. We present a case of a preterm infant with a UVC in situ who underwent a laparotomy on the first day of life for pneumoperitoneum secondary to meconium ileus. The operation was uneventful; however, 2 hours after surgery, the patient developed cardiac tamponade, requiring resuscitation and pericardiocentesis. In retrospect, near-infrared spectroscopy (NIRS) showed a gradual decline in cerebral oxygenation (crSO2) in the 30 min prior to the cardiac arrest, while other vital signs were within normal ranges. Our case demonstrates that cerebral NIRS monitoring can serve as an additional clinical marker for early recognition of impending cardiac tamponade.
- 9 December 2023
- Published by BMJ in BMJ Case Reports
- Vol. 16 (12) , e256014
Cerebral near-infrared spectroscopy for early recognition of impending cardiac tamponade in a preterm neonate
Cardiac tamponade is a rare but life-threatening complication of umbilical venous catheter (UVC) placement in neonates. Mortality rates are high; therefore, early diagnosis is important. We present a case of a preterm infant with a UVC in situ who underwent a laparotomy on the first day of life for pneumoperitoneum secondary to meconium ileus. The operation was uneventful; however, 2 hours after surgery, the patient developed cardiac tamponade, requiring resuscitation and pericardiocentesis. In retrospect, near-infrared spectroscopy (NIRS) showed a gradual decline in cerebral oxygenation (crSO2) in the 30 min prior to the cardiac arrest, while other vital signs were within normal ranges. Our case demonstrates that cerebral NIRS monitoring can serve as an additional clinical marker for early recognition of impending cardiac tamponade.
- 25 January 2023
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 21 (4) , 963-974
NEOnatal Central-venous Line Observational study on Thrombosis (NEOCLOT): evaluation of a national guideline on management of neonatal catheter-related venous thrombosis
- 25 January 2023
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 21 (4) , 963-974
NEOnatal Central-venous Line Observational study on Thrombosis (NEOCLOT): evaluation of a national guideline on management of neonatal catheter-related venous thrombosis
- 24 March 2022
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 43 (4) , 639-644
Early Ultrasonic Monitoring of Brain Growth and Later Neurodevelopmental Outcome in Very Preterm Infants
BACKGROUND AND PURPOSE: In infants born very preterm, monitoring of early brain growth could contribute to prediction of later neurodevelopment. Therefore, our aim was to investigate associations between 2 early cranial ultrasound markers (corpus callosum–fastigium and corpus callosum length) and neurodevelopmental outcome and the added value of both markers in the prediction of neurodevelopmental outcome based on neonatal risk factors and head circumference in very preterm infants. MATERIALS AND METHODS: This prospective observational study included 225 infants born at <30 weeks’ gestational age, of whom 153 were without any brain injury on cranial ultrasound. Corpus callosum–fastigium and corpus callosum length and head circumference were measured at birth, 29 weeks’ gestational age, transfer from the neonatal intensive care unit to a level II hospital, and 2 months’ corrected age. We analyzed associations of brain markers and their growth with cognitive, motor, language, and behavioral outcome at 2 years’ corrected age. RESULTS: In infants without brain injury, greater corpus callosum–fastigium length at 2 months was associated with better cognitive outcome. Corpus callosum length at 2 months was positively associated with cognitive, motor, and language outcome. Faster growth of the corpus callosum length between birth and 2 months was associated with better cognitive and motor function. Prediction of neurodevelopmental outcome based on neonatal risk factors with or without head circumference was significantly improved by adding corpus callosum length. CONCLUSIONS: Both corpus callosum–fastigium and corpus callosum length on cranial ultrasound are associated with neurodevelopmental outcome of very preterm infants without brain injury at 2 years, but only corpus callosum length shows the added clinical utility in predicting neurodevelopmental outcome.
- 24 March 2022
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 43 (4) , 639-644
Early Ultrasonic Monitoring of Brain Growth and Later Neurodevelopmental Outcome in Very Preterm Infants
BACKGROUND AND PURPOSE: In infants born very preterm, monitoring of early brain growth could contribute to prediction of later neurodevelopment. Therefore, our aim was to investigate associations between 2 early cranial ultrasound markers (corpus callosum–fastigium and corpus callosum length) and neurodevelopmental outcome and the added value of both markers in the prediction of neurodevelopmental outcome based on neonatal risk factors and head circumference in very preterm infants. MATERIALS AND METHODS: This prospective observational study included 225 infants born at <30 weeks’ gestational age, of whom 153 were without any brain injury on cranial ultrasound. Corpus callosum–fastigium and corpus callosum length and head circumference were measured at birth, 29 weeks’ gestational age, transfer from the neonatal intensive care unit to a level II hospital, and 2 months’ corrected age. We analyzed associations of brain markers and their growth with cognitive, motor, language, and behavioral outcome at 2 years’ corrected age. RESULTS: In infants without brain injury, greater corpus callosum–fastigium length at 2 months was associated with better cognitive outcome. Corpus callosum length at 2 months was positively associated with cognitive, motor, and language outcome. Faster growth of the corpus callosum length between birth and 2 months was associated with better cognitive and motor function. Prediction of neurodevelopmental outcome based on neonatal risk factors with or without head circumference was significantly improved by adding corpus callosum length. CONCLUSIONS: Both corpus callosum–fastigium and corpus callosum length on cranial ultrasound are associated with neurodevelopmental outcome of very preterm infants without brain injury at 2 years, but only corpus callosum length shows the added clinical utility in predicting neurodevelopmental outcome.